RN7SL323P

Across TCGA pan-cancer cohorts, RN7SL323P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL323P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SL323P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL323P is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, BRCA, and LUSC are the cancer types where RN7SL323P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL323P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.086	.003	6	view →
BRCA	All	II,III,IV	−0.024	.038	2	view →
LUSC	All	All	−0.079	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL323P–THCA

Open the THCA breakdown →